Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Current Drug Targets|March 14, 2007
Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agentsJ S Oliveira, I B Vasconcelos, I S Moreira, et al.Current Medicinal Chemistry|March 4, 2011
Pyrimidine salvage pathway in Mycobacterium tuberculosisA D Villela, Z A Sánchez-Quitian, R G Ducati, et al.Current Medicinal Chemistry|March 4, 2011
Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug developmentD M Saidemberg, A W Passarelli, A V Rodrigues, et al.Protein and Peptide Letters|October 16, 2008
Structural bioinformatics study of PNP from Listeria monocytogenesL F S M Timmers, R A Caceres, L A Basso, et al.Biochemistry|July 11, 2001
Purine nucleoside phosphorylase from Mycobacterium tuberculosis. Analysis of inhibition by a transition-state analogue and dissection by partsL A Basso, D S Santos, W Shi, et al.Journal of Periodontal Research|June 25, 2010
Purine nucleoside phosphorylase activity and expression are upregulated in sites affected by periodontal diseaseE L Batista, C Deves, L Ayub, et al.Biochemistry|July 11, 2001
Structures of purine nucleoside phosphorylase from Mycobacterium tuberculosis in complexes with immucillin-H and its piecesW Shi, L A Basso, D S Santos, et al.Current Drug Targets|March 14, 2007
Purine nucleoside phosphorylase: a potential target for the development of drugs to treat T-cell- and apicomplexan parasite-mediated diseasesR G Silva, J E S Nunes, F Canduri, et al.Biochemical and Biophysical Research Communications|March 5, 2017
Validation of Mycobacterium tuberculosis dihydroneopterin aldolase as a molecular target for anti-tuberculosis drug developmentV C A Falcão, A D Villela, V S Rodrigues-Junior, et al.Pageof 2